Tenopress 25 mg, 50 mg, 100 mg Film-coated tablets
PDF Leaflet Revision Date: 20 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Management of mild to moderate hypertension and angina pectoris.
Dosage (summary)
Adults: 50 to 100 mg once daily; elderly: 50 mg once daily.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; may cause fetal growth retardation and neonatal hypotonia.
Key Drug Interactions
- Hypoglycaemic agents
- Phenothiazines
- Antiarrhythmic agents
- Calcium antagonists
Contraindications
- Hypersensitivity to atenolol
- Cardiogenic shock
- Heart block
- Bradycardia
- Severe peripheral arterial disease
Common side effects
- Bradycardia
- Dizziness
- Fatigue
- Cold extremities
- Nausea
Counselling Points
- Monitor heart rate
- Avoid abrupt discontinuation
- Report any signs of severe allergic reactions
Serious warnings
- Caution in asthma
- Risk of rebound hypertension with clonidine withdrawal
- Gradual discontinuation recommended
Important Disclaimer
The Tenopress 25 mg, 50 mg, 100 mg Film-coated tablets professional information leaflet below is the property of Austell Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
